Live Breaking News & Updates on Vikas dandekar

Stay informed with the latest breaking news from Vikas dandekar on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vikas dandekar and stay connected to the pulse of your community

DigiPharmaX Awards 2024: Celebrating Pharma Excellence

DigiPharmaX Awards 2024: Celebrating Pharma Excellence
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

India , Mumbai , Maharashtra , Bharat , Globalspace-technologie , Sudarshan-jain , Debashish-roy , Pharmaceuticals-india-private-ltd , Vaccines-ltd , Wockhardt-ltd , Cadila-pharmaceuticals , Gufic-biosciences-ltd

DigiPharmaX Awards 2024 Celebrating Pharma Excellence

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Mumbai , Maharashtra , India , Bharat , Sudarshan-jain , Globalspace-technologie , Debashish-roy , Pfizer , Servier-india-private-ltd , Cadila-pharmaceuticals , Meghmani-life-sciences , Mumbai-jio-convention-centre-on

There can't be shortage of Polio vaccine; Serum Institute can make it: CEO Adar Poonawalla

Pune-based Serum Institute of India (SII) is prepared to increase production of injectable poliomyelitis vaccine (IPV) to fill the gap left by France's Sanofi closing its manufacturing plants in India. SII currently supplies half of the 20 million IPV doses to the government's immunization program and can provide additional doses with a 3-4 month notice. Adar Poonawalla, SII CEO, stated that supplying IPV to the government at current prices is unviable for most companies, but SII continues to do so as a service to the nation.

India , Netherlands , Dutch , Vikas-dandekar , Adar-poonawalla , Teena-thacker , Serum-institute-of-india , There-can-t , Polio-vaccine , Serum-can-make , Serum-institute , Bilthoven-biologicals

Morning Brief Podcast: India's breakthrough in cancer cure | The Economic Times Podcast

Morning Brief Podcast: India's breakthrough in cancer cure | The Economic Times Podcast
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

India , Thejna-john , Vikas-dandekar , Shirish-arya , Anirban-chowdhury , Hasmukh-jain , Tata-memorial-centre , Read-moreinto , Associate-professor , Memorial-centre , Chief-business-officer , Morning-brief

'Weight-loss Drug may be Launched in India Next Year'

At a market cap that exceeds $720 billion, US drug maker Eli Lilly tops the list of worlds most valuable pharmaceutical companies. The key to that is recent US approval for its weight-loss drug Zepbound (tirzepatide).

India , Bengaluru , Karnataka , Dubai , Dubayy , United-arab-emirates , Eli-lilly , Teena-thacker-vikas-dandekar , David-ricks , International-council-of-harmonisation , Teena-thacker , Vikas-dandekar

Eli Lilly: Weight-loss drug may be launched in India next year, says Eli Lilly CEO David Ricks

US drug maker Eli Lilly plans to launch its weight-loss drugs Zepbound and Mounjaro in India next year. The company is considering pricing based on supply and volume expansion. Eli Lilly CEO David Ricks suggests focusing on digital services in the Indian healthcare industry to encourage innovation and improve access to healthcare.

Hyderabad , Andhra-pradesh , India , Dubai , Dubayy , United-arab-emirates , Bengaluru , Karnataka , Eli-lilly , David-ricks , Teena-thacker-vikas-dandekar , International-council-of-harmonisation

cipla: Morning Brief Podcast: Cipla saga: Did the doctor prescribe a sale?

There is a buzz again that Cipla is toying with the idea of selling out to private-equity firms Baring Asia and Blackstone, at least partially, if not seeking a full exit. In this episode of The Morning Brief, Vikas Dandekar, Editor - Pharma and Life Sciences at ET Prime, walks down memory lane with host Anupriya Nair. Also discussed in this episode is, why the speculated Cipla sale is not a mere M&A deal and what could be on the mind of founder Yusuf Hamied. But emotions aside, do the valuations add up to excite investors? ET's Arijit Barman gives us the buzz from the deal makers. Listen in!

Vikas-dandekar , Arijit-barman , Anupriya-nair , Yusuf-hamied , Cipla , Life-sciences , Baring-asia , Morning-brief , Read-mores , Podcasts , Morning-brief-podcast , M-ampa-deal

Experts to deliberate on key issues at BioAsia 2023

The delegates will witness several panel discussions around compelling global health topics during the event, which is scheduled to happen in Hyderabad on February 24-26, 2023

Germany , Hyderabad , Andhra-pradesh , India , United-states , United-kingdom , Singapore , Belgium , China , World-trade-center , Illinois , Vellore

Morning Brief: Pat(i)ent rights: Will waiver of IP rights on Covid vaccines, drugs help developing nations like India?

Morning Brief (ET Bureau)
Pat(i)ent rights: Will waiver of IP rights on Covid vaccines, drugs help developing nations like India?
Devina Sengupta | 21:31 Min | May 11, 2021, 6:58 PM IST
A waiver of intellectual property rights on Covid-19 vaccines and drugs alone may not benefit developing countries including India in the battle against the deadly disease. Murali Neelakantan, Former Global General Counsel of Cipla and Glenmark, and Vikas Dandekar, Editor, Pharma and Healthcare, ET Prime, explain what’s at stake for the patent holders and developing nations. The clip featuring Bill Gates used in the podcast belongs to Sky News.
Tags

India , Vikas-dandekar , Murali-neelakantan , Bill-gates , Cipla , இந்தியா , விகாஸ்-தண்டேகர் , ர-சி-து-வாயில்கள் , சிப்லா ,

The Ongoing COVID-19 Crisis In India: Updates

India continues to shatter its own world records in newly reported COVID-19 cases, while thousands die each day amid the world’s worst outbreak of the coronavirus. On Friday the U.S. announced that it would restrict travel from the country.

India , New-york , United-states , Mumbai , Maharashtra , New-delhi , Delhi , White-house , District-of-columbia , Brazil , China , South-africa